Companies › IRMD

IRADIMED CORP (IRMD)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001325618 · EDGAR filings · Updated 2026-07-28

IRADIMED CORP (IRMD) has reported institutional ownership of 59.6%, with 226 institutional managers holding positions valued at $731.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Filings this week (1)

• 2026-07-28 — SCHEDULE 13G filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-24 — Current report (8-K) filed
• 2026-06-23 — Insider transaction reported (Form 4)
• 2026-06-04 — Insider transaction reported (Form 4)
• 2026-06-04 — Notice of proposed sale filed (Form 144)
• 2026-06-02 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IRADIMED CORP has 226 institutional holders and institutional ownership of 59.6%.

Insider activity

Insiders reported 97 transactions (0 buys, 77 sells) across 6 reporting insiders, with a net reported value of −$14.7M.

Data flags from SEC filings

Related companies

ARS PHARMACEUTICALS INC (SPRY) · SCHRODINGER INC (SDGR) · GERON CORP (GERN) · SOLID BIOSCIENCES INC (SLDB) · VOR BIOPHARMA INC (VOR) · JADE BIOSCIENCES INC (JBIO)